CONMED Corporation (CNMD) Social Stream
CONMED CORP (CNMD) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering CONMED CORP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-28 | 7 | $175 | $155 | $162.166 | $108.36 | 49.65% |
| 2022-01-24 | 6 | $175 | $150 | $160.833 | $108.36 | 48.42% |
| 2022-01-27 | 7 | $175 | $145 | $156.333 | $108.36 | 44.27% |
| 2022-05-06 | 8 | $175 | $145 | $157.857 | $108.36 | 45.68% |
| 2022-06-02 | 7 | $160 | $145 | $155 | $108.36 | 43.04% |
| 2022-07-19 | 6 | $160 | $110 | $144 | $108.36 | 32.89% |
| 2022-08-02 | 6 | $127 | $118 | $122 | $108.36 | 12.59% |
| 2022-10-03 | 6 | $125 | $118 | $121.2 | $108.36 | 11.85% |
| 2022-10-12 | 7 | $125 | $85 | $115.166 | $108.36 | 6.28% |
| 2022-10-14 | 7 | $125 | $85 | $109.666 | $108.36 | 1.21% |
| 2022-10-21 | 7 | $125 | $85 | $105.333 | $108.36 | -2.79% |
| 2022-11-15 | 7 | $108 | $83 | $95.833 | $108.36 | -11.56% |
| 2022-11-16 | 7 | $108 | $83 | $98.5 | $108.36 | -9.1% |
| 2023-01-27 | 7 | $108 | $83 | $100.5 | $108.36 | -7.25% |
| 2023-02-03 | 7 | $118 | $100 | $107.833 | $108.36 | -0.49% |
| 2023-02-08 | 7 | $122 | $100 | $112.166 | $108.36 | 3.51% |
| 2023-03-21 | 8 | $122 | $96 | $109.857 | $108.36 | 1.38% |
| 2023-03-26 | 8 | $124 | $96 | $111.625 | $108.36 | 3.01% |
| 2023-04-27 | 8 | $135 | $96 | $120.75 | $108.36 | 11.43% |
| 2023-06-06 | 9 | $140 | $96 | $125.444 | $108.36 | 15.77% |
| 2023-07-24 | 9 | $140 | $96 | $126 | $108.36 | 16.28% |
| 2023-07-27 | 9 | $145 | $96 | $131.333 | $108.36 | 21.2% |
| 2023-08-09 | 9 | $145 | $123 | $136.888 | $108.36 | 26.33% |
| 2023-10-17 | 8 | $145 | $123 | $136.375 | $108.36 | 25.85% |
| 2023-10-26 | 8 | $145 | $107 | $127.25 | $108.36 | 17.43% |
| 2023-11-06 | 8 | $142 | $107 | $123.375 | $108.36 | 13.86% |
The Trend in the Analyst Price Target
Over the past 16 months, CNMD's average price target has gone down $20.62.
Over the past 40 weeks, CNMD's average upside potential has been 12.69%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-08 | 7 | 122 | 100 | 112.166 | 104.12 | 7.73% |
| 2023-04-27 | 8 | 135 | 96 | 120.750 | 128.18 | -5.8% |
| 2023-05-22 | 9 | 140 | 96 | 125.000 | 120.50 | 3.73% |
| 2023-08-09 | 9 | 145 | 123 | 136.888 | 112.83 | 21.32% |
| 2023-09-28 | 8 | 145 | 123 | 136.375 | 101.49 | 34.37% |
CNMD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 3 | 2 | 3 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
CNMD's average broker recommendation rating worsened by 0.17 over the prior 15 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, CONMED CORP's average analyst price target is greater than 2794.32% of them.
- CNMD has a lower variance in analysts' estimates than -746.66% of all US stocks.
- CNMD has a higher upside potential (average analyst target price relative to current price) than 886.83% of Healthcare stocks.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, CONMED CORP's number of analysts covering the stock is higher than 1692.74% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to CONMED CORP are INSP, IRTC, and GKOS.
View All Top Stocks by Price Target
Is CNMD a Buy, Hold or Sell? See the POWR Ratings now!